Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Intermittent versus continuous central administration of clozapine in DBA/2 mice, improvement in sensory inhibition deficits.

Stevens KE, Zheng L, Abrams DJ.

Schizophr Res. 2013 Sep;149(1-3):121-6. doi: 10.1016/j.schres.2013.06.007. Epub 2013 Jul 15.

PMID:
23863771
2.

Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism.

Simosky JK, Stevens KE, Adler LE, Freedman R.

Psychopharmacology (Berl). 2003 Feb;165(4):386-96. Epub 2002 Nov 30.

PMID:
12459928
3.

Acute administration of Δ⁹ tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice.

Smucny J, Stevens KE, Tregellas JR.

Pharmacol Biochem Behav. 2014 Mar;118:22-9. doi: 10.1016/j.pbb.2014.01.001. Epub 2014 Jan 10.

4.

Olanzapine improves deficient sensory inhibition in DBA/2 mice.

Simosky JK, Freedman R, Stevens KE.

Brain Res. 2008 Oct 3;1233:129-36. doi: 10.1016/j.brainres.2008.07.057. Epub 2008 Jul 25.

5.

Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice.

Simosky JK, Stevens KE, Kem WR, Freedman R.

Biol Psychiatry. 2001 Oct 1;50(7):493-500.

PMID:
11600102
6.

The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain.

Feuerbach D, Lingenhoehl K, Olpe HR, Vassout A, Gentsch C, Chaperon F, Nozulak J, Enz A, Bilbe G, McAllister K, Hoyer D.

Neuropharmacology. 2009 Jan;56(1):254-63. doi: 10.1016/j.neuropharm.2008.08.025. Epub 2008 Aug 28.

PMID:
18793655
7.

Effects of the novel α7 nicotinic acetylcholine receptor agonist ABT-107 on sensory gating in DBA/2 mice: pharmacodynamic characterization.

Radek RJ, Robb HM, Stevens KE, Gopalakrishnan M, Bitner RS.

J Pharmacol Exp Ther. 2012 Dec;343(3):736-45. doi: 10.1124/jpet.112.197970. Epub 2012 Sep 17.

8.

Ondansetron results in improved auditory gating in DBA/2 mice through a cholinergic mechanism.

Wildeboer KM, Zheng L, Choo KS, Stevens KE.

Brain Res. 2009 Dec 1;1300:41-50. doi: 10.1016/j.brainres.2009.08.075. Epub 2009 Sep 1.

9.

Maximizing the effect of an α7 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits.

Stevens KE, Zheng L, Floyd KL, Stitzel JA.

Brain Res. 2015 Jun 22;1611:8-17. doi: 10.1016/j.brainres.2015.02.044. Epub 2015 Mar 2.

10.

Permanent improvement in deficient sensory inhibition in DBA/2 mice with increased perinatal choline.

Stevens KE, Adams CE, Yonchek J, Hickel C, Danielson J, Kisley MA.

Psychopharmacology (Berl). 2008 Jun;198(3):413-20. doi: 10.1007/s00213-008-1170-3. Epub 2008 Apr 30.

PMID:
18446322
11.

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.

Martin LF, Kem WR, Freedman R.

Psychopharmacology (Berl). 2004 Jun;174(1):54-64. Epub 2004 Feb 19. Review.

PMID:
15205879
12.

The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.

Wildeboer-Andrud KM, Stevens KE.

Pharmacol Biochem Behav. 2011 Nov;100(1):17-24. doi: 10.1016/j.pbb.2011.07.001. Epub 2011 Jul 7.

13.

Cotinine impacts sensory processing in DBA/2 mice through changes in the conditioning amplitude.

Wildeboer-Andrud KM, Zheng L, Choo KS, Stevens KE.

Pharmacol Biochem Behav. 2014 Feb;117:144-50. doi: 10.1016/j.pbb.2013.12.005. Epub 2013 Dec 26.

14.

An initial animal proof-of-concept study for central administration of clozapine to schizophrenia patients.

Abrams DJ, Zheng L, Choo KS, Yang JJ, Wei W, Anchordoquy TJ, Zawia NH, Stevens KE.

Schizophr Res. 2008 Mar;100(1-3):86-96. doi: 10.1016/j.schres.2007.10.012. Epub 2008 Jan 7.

15.

Effects of phencyclidine on auditory gating in the rat hippocampus and the medial prefrontal cortex.

Dissanayake DW, Zachariou M, Marsden CA, Mason R.

Brain Res. 2009 Nov 17;1298:153-60. doi: 10.1016/j.brainres.2009.08.032. Epub 2009 Aug 20.

PMID:
19699183
17.

Effects of a ketogenic diet on auditory gating in DBA/2 mice: A proof-of-concept study.

Tregellas JR, Smucny J, Legget KT, Stevens KE.

Schizophr Res. 2015 Dec;169(1-3):351-354. doi: 10.1016/j.schres.2015.09.022. Epub 2015 Oct 9.

18.

Long-term improvements in sensory inhibition with gestational choline supplementation linked to α7 nicotinic receptors through studies in Chrna7 null mutation mice.

Stevens KE, Choo KS, Stitzel JA, Marks MJ, Adams CE.

Brain Res. 2014 Mar 13;1552:26-33. doi: 10.1016/j.brainres.2014.01.022. Epub 2014 Jan 23.

19.

STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating.

Fradley RL, O'Meara GF, Newman RJ, Andrieux A, Job D, Reynolds DS.

Behav Brain Res. 2005 Sep 8;163(2):257-64.

PMID:
16046005
20.

Supplemental Content

Support Center